“…10,12,17,20 Serratia marcescens is well recognized as a nosocomial pathogen and has been responsible for outbreaks in neonatal and pediatric intensive care units 21 and outbreaks of bloodstream infection associated with intravenous drug solutions. 15 Moreover, respiratory colonization with S. marcescens has been a risk factor for outbreaks of bloodstream infection. 18 Drug-resistant S. marcescens isolates have been emerging in medical settings; these isolates produce aminoglycoside modification enzymes [AAC(6¢)-Ib, AAC(6¢)-Ib-cr, AAC(6¢)-Ic, AAC(6¢)-Iid, and ANT(3")-Ii], 3,4,13,19 16S rRNA methylases (ArmA and RmtB), 1,2 and metallo-blactamases, 9,11,23 although S. marcescens is naturally resistant to tetracycline, amoxicillin, amoxicillin-clavulanate, cephalothin, and colistin.…”